Steven Gillis, Director at Bluebird Bio, holds 1.05M shares in VBI Vaccines (Ticker: VBIVQ), holds 8.75K shares in Codiak BioSciences (Ticker: CDAKQ), holds 3.44M shares in Pulmatrix (Ticker: PULM). Most recently, Steven Gillis Bought ― shares of VBI Vaccines on Jul 18, 2023 for an estimated value of 1.00M.
What is the percentage of profitable transactions made by Steven Gillis?
The percentage of profitable transactions made by Steven Gillis is 43%.
What is the average return per transaction made by Steven Gillis?
The average return per transaction made by Steven Gillis is -5.40%.
What stocks does Steven Gillis hold?
Steven Gillis holds: BLUE, QTTB, PULM, CDAKQ, VBIVQ stocks.
What was Steven Gillis’s latest transaction?
Steven Gillis latest transaction was an Informative Buy of $1.00M.
What was Steven Gillis's most profitable transaction?
Steven Gillis’s most profitable transaction was an Informative Buy of VBIVQ stock on September 23, 2019. The return on the trade was 487.00%.
What is Steven Gillis's role in Bluebird Bio?
Steven Gillis's role in Bluebird Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.